Phase IV-Cervical Dystonia-INTEREST IN CD2 (INTEREST_INCD2)

Ipsen

Status: Completed

Conditions: Cervical Dystonia

Treatments: Biological: Botulinum toxin type A

Study type: Observational

Funder types: Industry

Identifiers

NCT01753349

Y-79-52120-166

Details and patient eligibility

About

The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).

Enrollment: 1,050 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject for whom there is an intention to treat with BoNT-A.
• BoNT treatment naïve or previously treated with BoNT.
• If previously treated with BoNT, at least a 12-week interval between the last injection (BoNT-A or BoNT-B) and inclusion.
• Subject able to comply with the protocol.
• Provision of written informed consent prior to collect the data.

Exclusion criteria

• Contraindications to any BoNT-A preparations.
• The subject has already been included in the study.

Trial design

1,050 participants in 1 patient group

Idiopathic cervical dystonia

Description:

Adults subjects from Hospitals, Private Practices suffering idiopathic cervical dystonia. BoNT-A injections, 3-4 times yearly.

Treatment:

Biological: Botulinum toxin type A